Dual JAK1/TYK2 inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Dual JAK1/TYK2 inhibitor, covering 2024-07-15 to 2024-07-15. Get the full timeline:
Most recent: Clinical Trial Update: Dual JAK1/TYK2 Inhibitor for Cicatricial Alopecia [Phase 2]